Soleno Therapeutics, Inc.

$SLNO is down slightly so far this week after last weeks meteoric rise. It’s still holding up pretty well and just above the price where it gapped down in the early part of 2021. Last Tuesday the company announced positive results for the treatment of rare genetic disease, Prader Willi syndrome. A genetic disease that causes obesity, intellectual disability and short stature.

Share This Article

 

About the Author

Soleno Therapeutics, Inc.

Joey Ramson